Chemical Structure : Refametinib
CAS No.: 923032-37-5
货号: PC-44028Not For Human Use, Lab Use Only.
Refametinib (BAY 86-97661, RDEA-119) is a potent, non-ATP-competitive, highly selective, allosteric inhibitor of MEK1/2 with IC50 of 19/47 nM respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥880 | In stock | |
25 mg | ¥1480 | In stock | |
50 mg | ¥2380 | In stock | |
100 mg | ¥3880 | In stock | |
200 mg | Get quote | ||
1 g | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Refametinib (BAY 86-97661, RDEA-119) is a potent, non-ATP-competitive, highly selective, allosteric inhibitor of MEK1/2 with IC50 of 19/47 nM respectively.
Refametinib inhibits anchorage-dependent growth of human cancer cell lines harboring the gain-of-function V600E BRAF mutant with GI50 of 67-89 nM.
Refametinib exhibits complete suppression of ERK phosphorylation at fully efficacious doses in mice and orally bioactive.
分子量 | 572.3372 | |
分子式 | C19H20F3IN2O5S | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
DMSO: ≥ 31 mg/mL |
|
Chemical Name/SMILES |
Cyclopropanesulfonamide, N-[3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl]-1-[(2S)-2,3-dihydroxypropyl]- |
1. Iverson C, et al. Cancer Res. 2009 Sep 1;69(17):6839-47.
2. Chang Q, et al. BMC Cancer. 2010 Sep 28;10:515.
3. Schmieder R, et al. Neoplasia. 2013 Oct;15(10):1161-71.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright